Semaglutide is a GLP-1 receptor agonist sold by Novo Nordisk under the brand names Wegovy and Ozempic
injectable dose in the evening Hair loss focus: Topical GHK-Cu serum applied to scalp daily, optionally supplemented with 1 mg/day SubQ for systemic follicle support Post-menopause skin support: 1.52 mg/day injectable is commonly used in this context, where estrogen-driven collagen decline accelerates skin thinning Combining Routes: Using topical GHK-Cu for skin alongside injectable GHK-Cu is a popular protocol among women because the two routes complement each other topical addresses surface skin quality directly, while injectable supports tissue repair and collagen signaling from within
Adequate sleep and stress management can support GHK-Cu's rebuilding processes
Alcohol can complicate semaglutide treatment in several ways
Real-time polymerase chain reaction (PCR) was performed with Takyon Rox SYBR master mix (Eurogentec, Seraing, Belgium) in a StepOnePlus (Applied Biosystems, Life Technologies, Foster City, CA, USA) using the following primers: IL-6 F 5ACTGGCAGAAAATAAGCTGAATCTTC 3 and R 5TGATCAAGCAAATCGCCTGAT3